NJ State Employees Deferred Compensation Plan’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Hold |
1,000
| – | – | 0.05% | 296 |
|
|
2025
Q1 | $485K | Hold |
1,000
| – | – | 0.06% | 275 |
|
|
2024
Q4 | $403K | Hold |
1,000
| – | – | 0.05% | 328 |
|
|
2024
Q3 | $465K | Hold |
1,000
| – | – | 0.06% | 306 |
|
|
2024
Q2 | $469K | Hold |
1,000
| – | – | 0.06% | 294 |
|
|
2024
Q1 | $418K | Hold |
1,000
| – | – | 0.05% | 321 |
|
|
2023
Q4 | $407K | Hold |
1,000
| – | – | 0.06% | 326 |
|
|
2023
Q3 | $348K | Hold |
1,000
| – | – | 0.05% | 333 |
|
|
2023
Q2 | $352K | Hold |
1,000
| – | – | 0.05% | 341 |
|
|
2023
Q1 | $315K | Hold |
1,000
| – | – | 0.05% | 367 |
|
|
2022
Q4 | $289K | Hold |
1,000
| – | – | 0.05% | 367 |
|
|
2022
Q3 | $290K | Hold |
1,000
| – | – | 0.05% | 362 |
|
|
2022
Q2 | $282K | Hold |
1,000
| – | – | 0.05% | 370 |
|
|
2022
Q1 | $261K | Hold |
1,000
| – | – | 0.04% | 416 |
|
|
2021
Q4 | $220K | Buy |
+1,000
| New | +$220K | 0.03% | 459 |
|
|
2021
Q3 | – | Sell |
-1,000
| Closed | -$202K | – | 510 |
|
|
2021
Q2 | $202K | Hold |
1,000
| – | – | 0.03% | 485 |
|
|
2021
Q1 | $215K | Hold |
1,000
| – | – | 0.03% | 468 |
|
|
2020
Q4 | $236K | Hold |
1,000
| – | – | 0.04% | 427 |
|
|
2020
Q3 | $272K | Hold |
1,000
| – | – | 0.05% | 351 |
|
|
2020
Q2 | $290K | Hold |
1,000
| – | – | 0.05% | 335 |
|
|
2020
Q1 | $238K | Hold |
1,000
| – | – | 0.05% | 342 |
|
|
2019
Q4 | $219K | Buy |
+1,000
| New | +$219K | 0.04% | 467 |
|